​

Aerovate Therapeutics Ownership | Who Owns Aerovate Therapeutics?

OverviewForecastFinancialsChart

Aerovate Therapeutics Ownership Summary

Aerovate Therapeutics is owned by 104.48% institutional investors, 0.02% insiders. Ra capital management is the largest institutional shareholder, holding 31.85% of AVTE shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.67% of its assets in Aerovate Therapeutics shares.

AVTE Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAerovate Therapeutics104.48%0.02%-4.49%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Ra capital management9.19M31.85%$24.36M
Sofinnova investments3.76M13.02%$9.96M
Tcg crossover management2.24M7.76%$5.94M
Atlas venture life science advisors1.80M6.23%$4.77M
Braidwell lp1.44M4.99%$3.82M
Logos global management lp1.40M4.85%$3.71M
Blackrock983.06K3.54%$1.63M
Vanguard group1.00M3.47%$2.66M
Blackrock funding, inc. /de975.42K3.38%$2.58M
Adar1 capital management928.02K3.22%$2.46M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Allostery investments lp850.68K2.35%$2.25M
Sofinnova investments3.76M0.73%$9.96M
Vazirani asset management75.00K0.62%$198.75K
Atlas venture life science advisors1.80M0.58%$4.77M
Tcg crossover management2.24M0.58%$5.94M
Adar1 capital management928.02K0.49%$2.46M
Logos global management lp1.40M0.43%$3.71M
Ra capital management9.19M0.32%$24.36M
Affinity asset advisors800.00K0.28%$2.12M
Fifth lane capital, lp50.00K0.12%$83.00K

Top Buyers

HolderShares% AssetsChange
Braidwell lp1.44M0.11%1.44M
Logos global management lp1.40M0.43%1.40M
Allostery investments lp850.68K2.35%850.68K
Adar1 capital management928.02K0.49%814.94K
Artal group809.60K0.03%809.60K

Top Sellers

HolderShares% AssetsChange
Deerfield management company, l.p. (series c)---1.41M
Frazier life sciences management---1.20M
Cormorant asset management, lp---1.07M
Great point partners---887.69K
Driehaus capital management---794.99K

New Positions

HolderShares% AssetsChangeValue
Braidwell lp1.44M0.11%1.44M$3.82M
Logos global management lp1.40M0.43%1.40M$3.71M
Allostery investments lp850.68K2.35%850.68K$2.25M
Artal group809.60K0.03%809.60K$1.34M
Jefferies financial group600.00K0.01%600.00K$1.59M

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-2.00
Gamma investing-80.00
Capital performance advisors llp-80.00
Fortitude family office-416.00
Metropolitan life insurance co/ny-701.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2024826.49%30,155,8309.09%1041.14%5028.21%13-18.75%
Sep 30, 202477-17.20%27,644,2911.70%951.00%39-37.10%1614.29%
Jun 30, 20249317.72%27,181,983-4.43%970.93%6255.00%14-39.13%
Mar 31, 20247925.40%28,443,1270.96%1020.89%4029.03%2335.29%
Dec 31, 2023638.62%28,171,582-1.03%1061.01%3129.17%1741.67%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv483.94K1.67%29.65K
iShares Russell 2000 ETF458.98K1.58%-3.96K
Vanguard VIF Small Co Gr213.89K0.74%-76.53K
Vanguard Institutional Extnd Mkt Idx Tr202.52K0.70%-
State St Russell Sm/Mid Cp® Indx NL Cl C172.19K0.59%-
State St Russell Sm/Mid Cp® Indx SL Cl I172.19K0.59%-
Fidelity Small Cap Index144.55K0.50%-2.71K
Bridge Builder Tax Managed Sm/Md Cp124.13K0.43%-
iShares Russell 2000 Growth ETF110.99K0.38%-528.00
Fidelity Extended Market Index68.22K0.24%-435.00

Recent Insider Transactions

DateNameRoleActivityValue
Jun 17, 2024RA CAPITAL MANAGEMENT, L.P. Buy$1.55M
Jun 14, 2024Eldridge George A SEE REMARKSSell$375.45K
Jun 14, 2024Verwijs Marinus CHIEF TECHNICAL OFFICERSell$265.00K
Jun 13, 2024Gillies Hunter CHIEF MEDICAL OFFICERSell$147.00K
May 17, 2024Gillies Hunter CHIEF MEDICAL OFFICERSell$82.45K

Insider Transactions Trends

DateBuySell
2024 Q3--
2024 Q2129
2024 Q1-23
2023 Q4-12
2023 Q3-10

AVTE Ownership FAQ

Who Owns Aerovate Therapeutics?

Aerovate Therapeutics shareholders are primarily institutional investors at 104.48%, followed by 0.02% insiders and -4.50% retail investors. The average institutional ownership in Aerovate Therapeutics's industry, Biotech Stocks , is 68.48%, which Aerovate Therapeutics exceeds.

Who owns the most shares of Aerovate Therapeutics?

Aerovate Therapeutics’s largest shareholders are Ra capital management (9.19M shares, 31.85%), Sofinnova investments (3.76M shares, 13.02%), and Tcg crossover management (2.24M shares, 7.76%). Together, they hold 52.63% of Aerovate Therapeutics’s total shares outstanding.

Does Blackrock own Aerovate Therapeutics?

Yes, BlackRock owns 3.54% of Aerovate Therapeutics, totaling 983.06K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 1.63M$. In the last quarter, BlackRock increased its holdings by 273.31K shares, a 38.51% change.

Who is Aerovate Therapeutics’s biggest shareholder by percentage of total assets invested?

Allostery investments lp is Aerovate Therapeutics’s biggest shareholder by percentage of total assets invested, with 2.35% of its assets in 850.68K Aerovate Therapeutics shares, valued at 2.25M$.

Who is the top mutual fund holder of Aerovate Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Aerovate Therapeutics shares, with 1.67% of its total shares outstanding invested in 483.94K Aerovate Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools